Matches in Wikidata for { <http://www.wikidata.org/entity/Q65538953> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q65538953 description "clinical trial" @default.
- Q65538953 description "ensayu clínicu" @default.
- Q65538953 description "klinisch onderzoek" @default.
- Q65538953 description "клінічне випробування" @default.
- Q65538953 name "Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer" @default.
- Q65538953 name "Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer" @default.
- Q65538953 type Item @default.
- Q65538953 label "Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer" @default.
- Q65538953 label "Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer" @default.
- Q65538953 prefLabel "Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer" @default.
- Q65538953 prefLabel "Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer" @default.
- Q65538953 P1132 Q65538953-15FADE04-46DB-4380-ACC2-D99328FAC37C @default.
- Q65538953 P1476 Q65538953-F7DD68D8-C760-43A2-8D86-14E11A3EF3AC @default.
- Q65538953 P17 Q65538953-9F91EBCE-A4B6-4BEF-B954-790F8C49360E @default.
- Q65538953 P17 Q65538953-DDD6874B-9003-478F-BA3F-7D84C0DF93F0 @default.
- Q65538953 P2899 Q65538953-0EFB44CD-E652-46C6-B7B0-35C15801A6D0 @default.
- Q65538953 P3098 Q65538953-322699B7-7899-48C6-97B7-B8D58499F801 @default.
- Q65538953 P31 Q65538953-3916DE98-3732-4EF5-BD2A-A19651C473A4 @default.
- Q65538953 P580 Q65538953-D36E9744-C802-488A-BEC8-234C3AF6BE01 @default.
- Q65538953 P582 Q65538953-ACA29170-445D-4AF5-927F-76C98B11AEAA @default.
- Q65538953 P6099 Q65538953-AE6BAAD6-4D86-4B39-BF34-A2302B6D2D45 @default.
- Q65538953 P6153 Q65538953-338D308B-D57D-4622-8E3A-CCAFDFAC0114 @default.
- Q65538953 P6153 Q65538953-4A9241D4-0828-4ED1-A688-40A0969CA66F @default.
- Q65538953 P6153 Q65538953-569B1771-D0E1-4AEA-A397-AD49CB84DB4E @default.
- Q65538953 P6153 Q65538953-59E94E22-C678-4910-8315-354E8E55D3CC @default.
- Q65538953 P6153 Q65538953-6B5E2B6E-0FBD-43E1-9B63-D4EE4619863F @default.
- Q65538953 P6153 Q65538953-8D682E8F-CE94-4D35-9518-A62AF09ACBA8 @default.
- Q65538953 P6153 Q65538953-8E10EC16-0D70-4254-A1EF-3CC47D8E5CC6 @default.
- Q65538953 P6153 Q65538953-9986C804-B282-490A-8EE6-252BB805361C @default.
- Q65538953 P6153 Q65538953-A7AD8865-7AFD-480D-9BC6-904B124B7090 @default.
- Q65538953 P6153 Q65538953-B7DCE39B-71F2-48A9-BE86-9F4D5BC54DCD @default.
- Q65538953 P8363 Q65538953-426B9E8F-3288-49F8-9E80-67DB1AE4A6F7 @default.
- Q65538953 P1132 "+74" @default.
- Q65538953 P1476 "A Phase 2 Study of AZD2171 in Recurrent or Persistent Ovarian, Peritoneal, or Fallopian Tube Cancer" @default.
- Q65538953 P17 Q16 @default.
- Q65538953 P17 Q30 @default.
- Q65538953 P2899 "+19" @default.
- Q65538953 P3098 "NCT00278343" @default.
- Q65538953 P31 Q30612 @default.
- Q65538953 P580 "2006-04-01T00:00:00Z" @default.
- Q65538953 P582 "2010-06-01T00:00:00Z" @default.
- Q65538953 P6099 Q42824440 @default.
- Q65538953 P6153 Q129421 @default.
- Q65538953 P6153 Q131252 @default.
- Q65538953 P6153 Q180865 @default.
- Q65538953 P6153 Q22033932 @default.
- Q65538953 P6153 Q230492 @default.
- Q65538953 P6153 Q4614 @default.
- Q65538953 P6153 Q6031854 @default.
- Q65538953 P6153 Q632891 @default.
- Q65538953 P6153 Q6694611 @default.
- Q65538953 P6153 Q6806307 @default.
- Q65538953 P8363 Q78089383 @default.